Avanos Medical Inc

10-Year Study

AVNS.US · Healthcare · US · Common Stock

Executive Summary: Avanos Medical Inc has compounded at -2.3% annually over the last 10 years, with a maximum drawdown of 84.6% and an annualized volatility of 42.4%.

1Y CAGR
+108.5%
3Y CAGR
+0.2%
5Y CAGR
-9.4%
10Y CAGR
-2.3%

History & Riski10-year historical performance analysis including CAGR, Max Drawdown, Sharpe & Sortino ratios, annual returns, and rolling volatility — all computed from daily market data.

10-Year Growth of $10,000

Max DrawdownMax DrawdownThe largest peak-to-trough decline in the asset's value over the measurement period.Click for full definition →
84.6%
Sharpe RatioSharpe RatioRisk-adjusted return: how much excess return you earn per unit of total risk (volatility).Click for full definition →
0.05
Sortino RatioSortino RatioLike Sharpe, but only penalizes downside volatility — a more accurate risk measure for asymmetric return distributions.Click for full definition →
0.12
Ann. VolatilityAnnualized VolatilityThe annualized standard deviation of an asset's returns — a measure of how much prices fluctuate.Click for full definition →
42.8%
Best YearBest & Worst YearThe single calendar year with the highest and lowest return in the measured period.Click for full definition →
2026 · +119.6%
Worst YearBest & Worst YearThe single calendar year with the highest and lowest return in the measured period.Click for full definition →
2025 · -29.5%
% Positive Years% Positive YearsThe percentage of calendar years in the measurement period where the asset delivered a positive return.Click for full definition →
30%

Annual Returns

Rolling 12-Month Returns

Rolling 12-Month Annualised Volatility

Historical Drawdowns

Monthly Returns

Monthly Returns Heatmap

YearJanFebMarAprMayJunJulAugSepOctNovDecAnn.
202618.65.9-0.676.0————————119.6%
20258.2-12.6-4.8-12.40.2-2.6-8.76.9-3.2-3.95.7-4.3-29.5%
2024-14.4-3.27.2-9.210.10.120.11.3-0.8-22.32.6-16.9-29.0%
202313.2-8.45.9-0.7-17.14.3-4.3-14.0-3.9-9.217.44.1-17.1%
2022-12.717.0-5.3-13.0-1.6-4.73.8-13.2-11.61.721.40.6-21.9%
2021-1.31.5-4.9-1.2-7.2-9.34.3-13.0-5.51.1-4.314.9-24.4%
2020-18.317.7-16.915.3-6.41.14.45.62.56.419.98.236.1%
20191.73.4-9.3-1.7-10.215.7-6.6-18.512.917.6-21.3-2.8-24.8%
20185.71.2-6.72.815.94.3-3.630.6-5.0-17.4-15.7-6.1-3.0%
20174.01.5-2.53.7-9.09.32.412.6-0.6-6.415.2-4.924.9%
2016———-2.010.44.66.45.4-4.9-6.714.8-0.528.7%

Risk X-RayiA 19-factor macroeconomic risk decomposition showing exactly which market forces (equity beta, rates, inflation, credit, commodity, crypto) drive this asset's volatility. Powered by multivariate regression against daily factor returns.

Risk Profile Insight: This asset has an estimated annualized volatility of 42.4%. The dominant macroeconomic risk driver is VTV.US, accounting for 27.0% of variance. Idiosyncratic stock-specific factors contribute 15.4%.

10-Year Historical Price Series (Growth of $10,000)
DateSimulated Value
2016-03-0110000
2016-04-019801.601113818308
2016-05-0110821.441002436479
2016-06-0111319.178558997564
2016-07-0112039.679777236339
2016-08-0112687.086668987122
2016-09-0112064.044552732334
2016-10-0111260.006961364428
2016-11-0112930.734423947093
2016-12-0112871.562826313955
2017-01-0113390.184476157325
2017-02-0113595.544726766446
2017-03-0113257.9185520362
2017-04-0113748.694744169858
2017-05-0112509.571876087713
2017-06-0113672.119735468152
2017-07-0113999.303863557258
2017-08-0115764.009745910196
2017-09-0115673.512008353639
2017-10-0114671.075530804037
2017-11-0116895.23146536721
2017-12-0116073.790462930734
2018-01-0116989.209885137487
2018-02-0117187.608771319177
2018-03-0116038.983640793595
2018-04-0116487.991646362687
2018-05-0119108.945353289244
2018-06-0119926.905673512007
2018-07-0119213.365819700663
2018-08-0125095.718760877127
2018-09-0123842.67316394013
2018-10-0119700.661329620605
2018-11-0116606.33484162896
2018-12-0115589.975635224504
2019-01-0115854.507483466758
2019-02-0116387.051862164983
2019-03-0114855.551688130872
2019-04-0114601.461886529762
2019-05-0113115.210581273928
2019-06-0115179.255134006264
2019-07-0114173.33797424295
2019-08-0111548.903585102678
2019-09-0113038.635572572224
2019-10-0115328.924469195961
2019-11-0112064.044552732334
2019-12-0111729.899060215803
2020-01-019585.798816568047
2020-02-0111280.891054646709
2020-03-019373.477201531501
2020-04-0110807.518273581622
2020-05-0110114.862513052558
2020-06-0110229.725026105116
2020-07-0110675.252349460496
2020-08-0111277.410372432996
2020-09-0111562.826313957536
2020-10-0112304.211625478594
2020-11-0114754.61190393317
2020-12-0115969.369996519317
2021-01-0115767.49042812391
2021-02-0116004.176818656455
2021-03-0115224.504002784546
2021-04-0115040.027845457711
2021-05-0113957.535676992691
2021-06-0112659.24121127741
2021-07-0113205.70831883049
2021-08-0111486.25130525583
2021-09-0110859.728506787329
2021-10-0110978.071702053603
2021-11-0110501.218238774802
2021-12-0112067.52523494605
2022-01-0110532.544378698225
2022-02-0112318.13435433345
2022-03-0111660.285415941526
2022-04-0110149.669335189697
2022-05-019986.077271145145
2022-06-019516.18517229377
2022-07-019874.695440306301
2022-08-018572.920292377305
2022-09-017580.925861468848
2022-10-017709.711103376261
2022-11-019363.035154890358
2022-12-019418.72607030978
2023-01-0110664.810302819353
2023-02-019770.274973894884
2023-03-0110351.548903585102
2023-04-0110281.935259310823
2023-05-018527.671423599024
2023-06-018896.623738252696
2023-07-018517.229376957883
2023-08-017323.355377654019
2023-09-017037.939436129481
2023-10-016390.532544378698
2023-11-017500.870170553429
2023-12-017807.17020536025
2024-01-016679.429168116952
2024-02-016463.62687086669
2024-03-016930.038287504351
2024-04-016293.073442394709
2024-05-016930.038287504351
2024-06-016933.518969718066
2024-07-018325.79185520362
2024-08-018430.212321615036
2024-09-018364.079359554473
2024-10-016501.914375217542
2024-11-016668.987121475809
2024-12-015541.24608423251
2025-01-015993.734772015315
2025-02-015238.426731639402
2025-03-014987.817612252002
2025-04-014368.25617821093
2025-05-014375.217542638357
2025-06-014260.355029585799
2025-07-013887.9220327184125
2025-08-014155.934563174382
2025-09-014023.6686390532545
2025-10-013867.0379394361294
2025-11-014086.3209189001045
2025-12-013908.806126000696
2026-01-014636.268708666898
2026-02-014907.7619213365815
2026-03-014876.435781413157
2026-04-018583.362339018448
Annual Return Matrix
YearAnnual Return
20170.24878312601406183
2018-0.030099610220874817
2019-0.2475999106943514
20200.3614243323442137
2021-0.24433304272013945
2022-0.21949812518027123
2023-0.17110125646711005
2024-0.2902362906821222
2025-0.29459798994974873
20261.1959038290293855
Total Factor Risk
0.4241572215533582
VTI.US Exposure
-0.1322656394345481
VEA.US Exposure
-0.07298529993572356
VWO.US Exposure
0.018322079456872333
QQQ.US Exposure
0.2246507498689551
VTV.US Exposure
0.2703034390562135
IJR.US Exposure
0.1957660451958894
QUAL.US Exposure
0.11000615876182239
SHV.US Exposure
0.02697345070304008
TLT.US Exposure
0.014156237178793737
LQD.US Exposure
0.06276097945951438
HYG.US Exposure
-0.016959632475614342
GLD.US Exposure
0.005301657759910977
USO.US Exposure
0.0018907093005391794
VNQ.US Exposure
0.05116374530577082
BTC-USD.CC Exposure
0.002933813901778123
CPER.US Exposure
0.0055086002400000856
VIX.INDX Exposure
0.024140815006193497
UUP.US Exposure
0.06089265783280013
TIP.US Exposure
-0.0067983523521572015
Idiosyncratic Exposure
0.15423778516994952
Value Score
50
Growth Score
50
Profit Score
37.5
Health Score
23.6
Yield Score
0
Moat Score
40

Factor Risk Decomposition

Share of annualised volatility attributable to each macro factor.

Total Est. Vol
42.4%

FundamentalsiCompany financial health metrics: P/E valuation, dividend yield, Piotroski F-Score (9-point profitability signal), Altman Z-Score (bankruptcy risk proxy), and a radar chart across 6 fundamental dimensions. Note: ETFs may show N/A for some metrics.

Fundamental Dimensions

Core Valuation

P/E Ratio (TTM)P/E RatioPrice-to-Earnings ratio — the market price of a stock divided by its earnings per share, a key valuation measure.Click for full definition →N/A
Dividend YieldDividend YieldAnnual dividend paid per share divided by the current share price — expressed as a percentage income return.Click for full definition →0.00%
Market Cap$648.8M
Piotroski F-ScorePiotroski F-ScoreA 9-point scoring system evaluating a company's financial strength across profitability, leverage, and operating efficiency.Click for full definition →
9-point profitability signal
0.0/ 9
Weak
Altman Z-ScoreAltman Z-ScoreA bankruptcy prediction model that combines 5 financial ratios into a single score indicating financial distress risk.Click for full definition →
Bankruptcy risk proxy
1.18
Distress Zone
Income Simulation

Based on $10,000 initial investment.

Total Income Generated
$0
Avg Yield on Cost
0.00%

Momentum & MacroiPrice momentum indicators relative to key technical levels: distance from 50-Day SMA (intermediate trend), 200-Day SMA (long-term trend), 52-Week High (bullish proximity), and Beta (market sensitivity coefficient).

vs 50-Day SMAMoving Averages (SMA)A rolling average of an asset's price over a defined window — used to identify trends and momentum signals.Click for full definition →
+68.0%
Above/below 50-day moving average
vs 200-Day SMAMoving Averages (SMA)A rolling average of an asset's price over a defined window — used to identify trends and momentum signals.Click for full definition →
+98.1%
Above/below 200-day moving average
vs 52-Week High52-Week HighThe highest price an asset reached in the past 52 weeks — a key reference for momentum and valuation context.Click for full definition →
0.2% from high
Distance from 52-week high
BetaBetaA measure of an asset's sensitivity to broad market movements relative to a benchmark (e.g. S&P 500).Click for full definition →
1.05
Market sensitivity coefficient

Frequently Asked Questions & Methodology

Is Avanos Medical Inc a high-risk investment?

Avanos Medical Inc (AVNS.US) has an annualized volatility of 42.4% and experienced a maximum drawdown of 84.6% over the last 10 years. Its primary macro risk driver is VTV.US.

What is the 10-year return of AVNS.US?

Over the past 10 years, AVNS.US has generated a Compound Annual Growth Rate (CAGR) of -2.3%. It has had a positive return in 30% of the years measured.

Data Methodology & Trust

The risk and return information on this page is pre-calculated mathematically using daily market data spanning a 10-year period. Fundamentals (such as P/E Ratio, Market Cap, and Dividend Yield) represent trailing averages and may not immediately reflect real-time live market fluctuations. Advanced scoring models like the Piotroski F-Score and Altman Z-Score are proxies applied to publicly available trailing-twelve-month financial statements and may not account for recent off-balance-sheet events, qualitative company shifts, or sector-specific capital structures. Macroeconomic factor exposures are estimated via multivariate regression against standard market indices. This data is provided for quantitative insight and backtesting research, and should not be misconstrued as tailored financial advice.

Run a Full Backtest on Avanos Medical Inc

stresstest.pro lets you simulate DCA vs Lump Sum, Monte Carlo projections, portfolio optimisation, and more — all in seconds.

Start a Free Backtest